Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer
- 1 May 2011
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 304 (2) , 137-143
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Cytosolic Phospholipase A2: Targeting Cancer through the Tumor VasculatureClinical Cancer Research, 2009
- Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer CellsJNCI: Journal of the National Cancer Institute, 2008
- Thrombin induced secretion of macrophage migration inhibitory factor (MIF) and its effect on nuclear signaling in endotheliumJournal of Cellular Biochemistry, 2008
- Ovarian cancer: front-line standard treatment in 2008Annals of Oncology, 2008
- Autotaxin (ATX): A multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular propertiesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocolBMC Cancer, 2007
- Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activityLife Sciences, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003
- Prolonged Wild-Type p53 Protein Accumulation and Cisplatin ResistanceBiochemical and Biophysical Research Communications, 2001